Pancreatic Cancer Research

ResearcherSecond Hospital of Tianjin Medical UniversityNo recent work listed

Geng Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0001-1674-3998; OpenAlex author ID A5112471941. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper

Papers 2

  1. Downregulation of miR-21 inhibits the malignant phenotype of pancreatic cancer cells by targeting VHL. Last author DOI 10.2147/ott.s211535↗
  2. FOXO3a expression and its diagnostic value in pancreatic ductal adenocarcinoma. Co-author PMID 31949625↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhijia Jiang · 2 shared papers, 2018–2019 · strength 0.21
  2. Jinjin Sun · 2 shared papers, 2018–2019 · strength 0.21
  3. Kaiqiang Wang · 1 shared paper, 2019 · strength 0.11
  4. Yanxun Li · 1 shared paper, 2019 · strength 0.11
  5. Dong Su Yu · 1 shared paper, 2018 · strength 0.10
  6. Shuang Feng · 1 shared paper, 2018 · strength 0.10
  7. Jun Li · 1 shared paper, 2018 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.